Perhexiline

This classification denotes a calcium channel blocker, cardiovascular agent, and vasodilator agent with the molecular formula C19H35N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier KU65374X44, chemically known as 2-(2,2-dicyclohexylethyl)piperidine but generally known as perhexiline, which bears US NIH Compound Identifier 4746. European Medicines Agency schedules Perhexiline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09726MIG. World Health Organization schedules perhexiline in its Anatomical Therapeutic Chemical (ATC) Classification. PERHEXILINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule perhexiline under HS 29333999 and SITC 51574. As of Q4 2014, PERHEXILINE remains the US FDA Preferred Term for this commodity. SMILES: N1C(CC(C2CCCCC2)C2CCCCC2)CCCC1.